SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001490978-24-000087
Filing Date
2024-11-12
Accepted
2024-11-12 06:47:22
Documents
13
Period of Report
2024-11-11
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K sdgr-20241111.htm   iXBRL 8-K 33159
  Complete submission text file 0001490978-24-000087.txt   162343

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sdgr-20241111.xsd EX-101.SCH 1794
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sdgr-20241111_lab.xml EX-101.LAB 22548
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sdgr-20241111_pre.xml EX-101.PRE 13054
16 EXTRACTED XBRL INSTANCE DOCUMENT sdgr-20241111_htm.xml XML 3223
Mailing Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036
Business Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036 503-299-1150
Schrodinger, Inc. (Filer) CIK: 0001490978 (see all company filings)

IRS No.: 954284541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39206 | Film No.: 241443118
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)